Enantiomeric selectivity of ruthenium (II) chiral complexes with antitumor activity, in vitro and in vivo.

Zhang, Weiwei; Sun, Yu; Wang, Jingyuan; Ding, Xiaoyuan; Yang, Endong; Martin, Lisandra L; Sun, Dongdong

Zhang, Weiwei; Sun, Yu; Wang, Jingyuan; Ding, Xiaoyuan; Yang, Endong; Martin, Lisandra L; Sun, Dongdong.

Affiliation

Zhang W; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China; School of Biochemical Engineering, Anhui Polytechnic University, Beijing Middle Road, 241000 Wuhu, Anhui, China.
Sun Y; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Wang J; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Ding X; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Yang E; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Martin LL; School of Chemistry, Monash University, Clayton 3800, Victoria, Australia. Electronic address: Lisa.Martin@monash.edu.
Sun D; School of Life Sciences, Anhui Agricultural University, Hefei 230036, China. Electronic address: sunddwj@126.com.

J Inorg Biochem ; 216: 111339, 2021 03.

Article in En | MEDLINE | ID: mdl-33388703

Subject(s)
Key words

AIE; Anticancer; Chiral complexes; Fluorescent probes; Ruthenium

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ruthenium / Coordination Complexes / Neoplasms, Experimental / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Inorg Biochem Year: 2021 Document type: Article Affiliation country: China Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google